 |
| |
 Roderick Beijersbergen, Ph.D.Group Leader, Molecular Carcinogensis, The Netherlands Cancer Institute; Netherlands
Read more |
Mark Collins, Ph.D.
Laboratory Automation and Cellular Imaging-Thermo Fisher Scientific; USA
Read more |
Anthony Davies, Ph.D. Director, High Content Research Facility, Trinity College Dublin; Ireland
Read more |
 Horst Flotow, Ph.D.
Group Leader, HTS, Experimental Therapeutics Centre; Singapore
Read more |
 |
|
|
|
 Edison Liu, M.D.
Executive Director, Genome Institute of Singapore;
President, HUGO; Chairman,
Health Science
Authority; Singapore
Read more
|
 Ruth Muschel, M.D., Ph.D University of Oxford; UK
Read more
|
 O. Joseph Trask, Jr., Ph.D. Head-Cellular Imaging Technologies, Center for Drug Discovery, Duke University; USA
Read more |
 Christopher W. Wong, Ph.D. Research Scientist, HCS Laboratory, Genome Institute of Singapore; Singapore
Read more |
|
|
| Panel Of International Speakers |
| |
Adam Szafran, Ph.D.  Speaker's Abstract
Baylor College of Medicine, Houston, TX |
|
Alexis Borisy, A.M. Speaker's Abstract
President and Chief Executive Officer, Founder, Combinatorx, Boston, MA |
|
Anthony Davies, Ph.D. Speaker's Abstract
High-Content Research Facility Director, Clinical Medicine, Trinity College Dublin, Ireland |
|
Anne E. Carpenter, Ph.D. Speaker's Abstract
Director, Imaging Platform, Broad Institute, Boston, MA |
|
Caty Chung, M.S. Speaker's Abstract
Collaborations Manager, Center for Computational Science, University of Miami, Miami, FL |
|
Chang Young Tae, Ph.D. Speaker's Abstract
Head, Lab of Bioimaging Probe Development, Singapore Bioimaging Consortium, Singapore |
|
D. Lansing Taylor, Ph.D. Speaker's Abstract
Chief Executive Officer, Cellumen, Inc., Pittsburgh, PA |
|
Sir David Lane, Ph.D.
"Chairman, Biomedical Research Council (BMRC), Singapore Executive Director, Institute of Molecular and Cell Biology, Singapore Chief Executive Officer, Experimental Therapeutics Centre, Singapore Chief Scientist, Cancer Research UK Director, CR-UK Cell Transformation Research Group, University of Dundee, Scotland" |
|
Eberhard Krausz, Ph.D. Speaker's Abstract
Director, Discovery Assay Technologies (DAT), Viral Diseases & Therapeutic Markers, Tibotec BVBA, Belgium |
|
Frederic Bard, Ph.D. Speaker's Abstract
Principal Investigator, Cell Structure and Function, Inst of Molecular and Cell Biology Singapore |
|
Horst Flotow, Ph.D. Speaker's Abstract
Group Leader, High Throughput Screening, Experimental Therapeutics Centre, Singapore |
|
Mark Collins, Ph.D.
Senior Marketing Manager, Thermo Fisher Scientific, Pittsburgh, PA |
|
Michael A. White, Ph.D. Speaker's Abstract
Professor, Cell Biology, Associate Director, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX |
|
Michael Boutros, Ph.D. Speaker's Abstract
Group Leader, German Cancer Research Centre (DKFZ), Heidelberg, Germany |
|
Mike Ignatius, Ph.D. Speaker's Abstract
First Director of Cell Biology, HCS and FLOW, Molecular Probes |
|
Namyong Kim, Ph.D. Speaker's Abstract
Chief Executive Officer, Curiox Biosystems, Singapore |
|
O. Joseph Trask, Jr., Ph.D. Speaker's Abstract
Head of Cellular Imaging Technologies, Center for Drug Discovery, Department of Neurobiology, Duke University, Durham, NC |
|
Paul Spellman, Ph.D. Speaker's Abstract
Computational Scientist, Cancer & Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, CA |
|
Peter O'Brien, Ph.D. Speaker's Abstract
Veterinary Clinical Pathologist, University College Dublin, Ireland |
|
Robert Morris Campbell, Ph.D.
Director, Oncology Drug Discovery Research, Lilly Singapore Centre for Drug Discovery, Singapore |
|
Roderick Beijersbergen, Ph.D. Speaker's Abstract
"Associate Professor Division of Molecular Carcinogenesis and Head NKI Robotics and Screening Center The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands" |
|
Stephan Heyse, Ph.D. Speaker's Abstract
Head, Genedata Screener, Genedata AG, Basel, Switzerland |
|
Stephan Schurer, Ph.D. Speaker's Abstract
Chemical Informatics Group Leader, The Scripps Research Institute, Jupiter, FL |
|
Thomas J Murphy, Ph.D. Speaker's Abstract
Chief Scientific Officer, Research Instruments, Singapore |
|
Vance Lemmon, Ph.D. Speaker's Abstract
Walter G. Ross Chair in Developmental Neuroscience, Professor of Neurological Surgery, University of Miami, FL |
|
Vivek Abraham, Ph.D. Speaker's Abstract
Associate Research Investigator, GPRD, Target & Lead Discovery, Abbott Laboratories, Abbott Park, IL |
|
W. Adam G. Hill, D.Phil. Speaker's Abstract
Director, Hits Discovery Group, Novartis Institutes for BioMedical Research, Inc., Boston, MA |
|
William Hahn, M.D., Ph.D. Speaker's Abstract
Assoc Prof of Medicine, Harvard Medical School, Dana-Farber Cancer Inst, Boston, MA |
|
Yan Feng, Ph.D. Speaker's Abstract
Lab Head, Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Boston, MA |
|
| |
|
|
